Search - tctmd.com

Displaying 901 - 920 of 1041

Sort: Relevancy | Date

News Conference News TCT 2014

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

September 16, 2014

News Industry News

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

September 16, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Conference News ESC 2014

Observational Studies Ask How Much Medication Adherence Matters After MI

Caitlin E. Cox

August 31, 2014

News Conference News ESC 2014

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

Yael L. Maxwell

August 31, 2014

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

August 28, 2014

News Industry News

Sanofi and Regeneron to Present Results from Four Phase 3 Alirocumab

August 25, 2014

News Industry News

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

July 30, 2014

News Daily News

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Leah Lawrence

July 03, 2014

News Daily News

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

June 04, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Industry News

US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia

May 06, 2014

News Daily News

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

April 30, 2014

News Industry News

Sanofi and Regeneron To Present Alirocumab Clinical Data at the American College of Cardiology's 63rd Annual Scientific Session

March 27, 2014

News Daily News

Registry Data Support Efficacy of Revascularization in Stable Patients

March 27, 2014

News Industry News

Phase 3 Pivotal Data on Amgen's Novel Investigational Cholesterol-Lowering Medicine to be Featured at the American College of Cardiology's 63rd Annual Scientific Session

March 24, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

News Daily News

Statins More Beneficial Before PCI Than After in ACS Patients

March 13, 2014

Advertisement

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Observational Studies Ask How Much Medication Adherence Matters After MI

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

Sanofi and Regeneron to Present Results from Four Phase 3 Alirocumab

Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

PROSPECT Substudy: Persistently High CRP Predicts Future MACE in ACS Patients After PCI

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

Sanofi and Regeneron To Present Alirocumab Clinical Data at the American College of Cardiology's 63rd Annual Scientific Session

Registry Data Support Efficacy of Revascularization in Stable Patients

Phase 3 Pivotal Data on Amgen's Novel Investigational Cholesterol-Lowering Medicine to be Featured at the American College of Cardiology's 63rd Annual Scientific Session

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

Statins More Beneficial Before PCI Than After in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content